Tunstall Healthcare and Qualcomm Collaborate for Global Deployment of Innovative Connected Care Services

Qualcomm Life, Inc.Qualcomm Life, Inc., a subsidiary of Qualcomm Incorporated (NASDAQ: QCOM), and Tunstall Healthcare, one of the leading providers of technology-enabled care services, announced its collaboration to facilitate the cost effective global deployment of Tunstall's care provisions leveraging Qualcomm Life's 2netâ„¢ Platform.

The 2net Platform is a cloud-based, device-agnostic and interoperable system that enables end-to-end connectivity with an expansive variety of medical devices and applications, allowing users and their clinicians or caregivers to easily access biometric data. It alleviates the challenges of interoperability by making it easier for customers to liberate data from a patient's medical device through seamless data acquisition and transmission to the manufacturer's interface of choice. The 2net Platform provides a comprehensive platform where near real-time data can be accessed by patients and clinicians, unlocking the potential for improved health care delivery.

Tunstall joins the large network of organisations that are leveraging the functionality of the open-standard 2net Platform as a Qualcomm Life Ecosystem member. As a member, Tunstall is able to meet its customers increasing expectations and deliver high-quality care and support worldwide. Through its collaboration with Qualcomm Life, Tunstall will add the 2net Hub and mobile applications to its product portfolio, in addition to integrating 2net into Tunstall's existing telehealth systems.

Rick Valencia, senior vice president and general manager of Qualcomm Life said, "We value the opportunity to work with Tunstall, because they bring a world-renowned reputation, industry experience and proven results in scalability, which supports our mission to broaden the scope of telehealthcare. As health care monitoring shifts from acute-care settings to less-costly settings, like the patient's home, our 2net Platform is bridging the technology gap. 2net is one of the only services on the market that combines a well-established, agnostic ecosystem of service providers and manufacturers, with a business model that supports scalability."

Steve Sadler, CTO, Tunstall commented, "Our collaboration with Qualcomm Life marks an important step in the development of our Bespoke care services, as we move towards an increasingly open-standard model of care provision. By joining the Qualcomm Life Ecosystem and integrating with the 2net Platform, we're able to provide our customers with access to a single source of information. We look forward to working closely with Qualcomm Life to extend our services further and identify opportunities for the ongoing integration of health and social care."

About Qualcomm Incorporated
Qualcomm Incorporated (NASDAQ: QCOM) is a world leader in 3G, 4G and next-generation wireless technologies. Qualcomm Incorporated includes Qualcomm's licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a wholly-owned subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm's engineering, research and development functions, and substantially all of its products and services businesses, including its semiconductor business, QCT. For more than 25 years, Qualcomm ideas and inventions have driven the evolution of digital communications, linkingpeople everywhere more closely to information, entertainment and each other. For more information, visit http://www.qualcommlife.com.

About Tunstall
Tunstall Healthcare Group is the market leading provider of telehealthcare solutions, with over 3.6 million users globally. Tunstall’s solutions support older people and those with long-term needs, helping them to live independently by effectively managing their health and well-being. Its solutions have been proven effective in the world's largest telehealthcare trial. Tunstall provides technology, services, expertise and advice to millions of people enabling them to lead independent more fulfil ling lives.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

Routine AI Assistance may Lead to Loss o…

The introduction of artificial intelligence (AI) to assist colonoscopies is linked to a reduction in the ability of endoscopists (health professionals who perform colonoscopies) to detect precancerous growths (adenomas) in...